Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
HIT Catalyst Timeline
Dated clinical, regulatory and corporate events for Health In Tech, Inc. Class A Common Stock
Past FDA Catalysts and PDUFA Decisions
How HIT actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
Health In Tech, Inc. Class A is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every HIT program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Hasan Zain SyedOfficer (Chief Growth Officer) | Sell | -1,667 171,993 held | $0.55 | 11/03/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in HIT
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in HIT for Q3 2026. | ||||
Ownership Trends
HIT Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How HIT ranks across every disease it competes in
HIT News
Health In Tech Appoints Wall Street Research and Capital Markets Veteran Christina R. Valauri to Board of Directors
Health In Tech appointed Christina R. Valauri to its Board of Directors, effective November 12, 2026. Valauri brings over 30 years of experience in financial services, including senior roles at major firms. She will serve on multiple committees and is expected to provide valuable insights for the company's growth and governance.
Read more →Health In Tech Reports Third Quarter 2026 Financial Results
Health In Tech reported a net loss of $7.1 million for Q3 2026, down from a profit of $0.5 million in Q3 2025. Revenue for the quarter was $6.6 million, a decline from $8.5 million year-over-year. The company has expanded its distribution partners by 15.9% and has a pipeline revenue of $156.4 million as of October 30, 2026.
Read more →Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026
Health In Tech, Inc. will announce its third quarter 2026 financial results on November 12, 2026. The company plans to host a conference call at 5:00 p.m. ET to discuss these results and its business outlook. The earnings call will be accessible via a live webcast and a replay will be available afterward.
Read more →Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion
Health In Tech appointed Sanjay Shrestha as CEO, effective October 20, 2026, succeeding founder Tim Johnson, who becomes Executive Chairman. This leadership change aims to enhance commercial execution and pursue strategic acquisitions. Shrestha's experience in scaling businesses will be pivotal in advancing the company's growth and operational capabilities.
Read more →Health In Tech to Host Annual Meeting of Stockholders
Health In Tech, Inc. will hold its 2026 Annual Meeting of Stockholders on November 10, 2026, at 10:00 AM ET via a live virtual webcast. Stockholders as of September 18, 2026, can vote electronically and submit questions during the meeting. Guests can listen in without a control number, and a replay will be available on the company's website.
Read more →Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
Health In Tech has launched HitRix, an AI-enabled platform designed to streamline the process of placing self-funded stop-loss health insurance. This broker-first marketplace allows brokers to manage submissions, compare quotes, and track cases from a single dashboard, significantly reducing operational inefficiencies. The platform aims to enhance decision-making and improve communication between brokers and market partners.
Read more →Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
Health In Tech, Inc. announced its participation in the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. The company's management will engage in one-on-one meetings with institutional investors at the event. Health In Tech aims to enhance processes in the health insurance sector through its AI-enabled InsurTech platform.
Read more →Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
Health In Tech, Inc. has launched HitRix, an AI-powered platform aimed at simplifying workflows in the self-funded health insurance market. The company also updated its revenue guidance for 2026 to approximately $33 million, aligning with 2025 figures. HitRix is expected to drive growth starting in 2027 as adoption increases and new initiatives take effect.
Read more →Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
Health In Tech, Inc. has been named one of Newsweek's America's Greatest Mid-Market Companies for 2026, ranking among the top 100 U.S. public mid-market companies. The recognition is based on a thorough evaluation of financial strength, workforce performance, innovation, and sustainability. CEO Tim Johnson highlighted the company's focus on AI-driven products and commitment to long-term sustainability.
Read more →Health In Tech Reports Second Quarter 2026 Financial Results
Health In Tech, Inc. reported its financial results for Q2 2026, showing a net loss of $2.5 million and a decrease in revenue compared to the previous year. Despite these challenges, the company noted a 19.9% increase in distribution partners and a robust pipeline revenue of $66.3 million. The CEO highlighted ongoing investments in growth and reaffirmed the company's revenue guidance for the year.
Read more →Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026
Health In Tech, Inc. will announce its second quarter 2026 financial results on August 13, 2026, following the market close. The company will host a conference call to discuss the results and its business outlook. This announcement corrects an earlier error regarding the date of the call.
Read more →Health In Tech Added to Membership of Russell Microcap® Index
Health In Tech, Inc. has been added to the Russell Microcap Index, effective June 29, 2026. This inclusion is part of the Russell U.S. indexes reconstitution and signifies recognition of the company's advancements in the InsurTech sector. CEO Tim Johnson expressed optimism that this milestone will enhance the company's visibility among institutional investors.
Read more →Q1 2026 Earnings Conference Call
The Health In Tech Q1 2026 earnings conference call highlighted the company's strategic focus on expanding sales distribution and technology enhancements. CEO Tim Johnson noted the substantial potential in the self-funded insurance market, where the company's current penetration remains low. A recent $7 million PIPE investment will support initiatives to grow their distribution network and improve technological capabilities. The call also included forward-looking statements regarding the business's growth outlook and market strategies.
Read more →Health In Tech Reports First Quarter 2026 Financial Results
Health In Tech, Inc. reported a 9.4% increase in revenue for Q1 2026, totaling $8.8 million. However, the company faced a net loss of $1.6 million, contrasting with a profit in the same quarter last year. The firm reiterated its revenue guidance for 2026, projecting between $45 million and $50 million, driven by growth in distribution partners and new product features.
Read more →An AI - Powered Marketplace Platform Helping SMBs Access Better Self - Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT,"
Health In Tech, Inc. has launched an AI-powered marketplace platform aimed at helping small and medium-sized businesses (SMBs) access improved self-funded health plans. The platform seeks to address the complexities that have historically limited SMBs from leveraging these plans, thus providing greater flexibility and cost benefits. Furthermore, HIT aims to streamline health plan administration and underwriting through its integrated system, facilitating quicker onboarding for employer groups. This innovative approach could disrupt the current landscape of healthcare insurance and enhance accessibility for smaller businesses.
Read more →Health In Tech to Present at the Market Movers Investor Summit
Health In Tech, Inc. will present at the Market Movers Investor Summit on May 5, 2026. The event is recognized as a premier Wall Street gathering, featuring company presentations and networking opportunities. Julia Qian, CFO of Health In Tech, will lead the company's presentation at 3:00 PM ET at the historic Bank of New York.
Read more →Health In Tech Announces Zain Hasan as Chief Growth Officer to Accelerate Revenue Growth and Scale Distribution
Health In Tech has appointed Zain Hasan as Chief Growth Officer to lead its growth strategy. Hasan, who joined the company in September 2025, will focus on revenue generation and performance across various sectors. The company is optimistic about entering a high-growth phase, leveraging its AI-enabled platform to enhance its offerings.
Read more →Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth
Health In Tech has appointed Sri Rajagopalan as Chief Technology Officer, effective February 23, 2026. Rajagopalan, who previously served as Interim CTO, will lead the company's technology strategy, focusing on AI development and platform modernization. His extensive experience in enterprise architecture and healthcare technology is expected to enhance the company's operational capabilities and support future growth initiatives.
Read more →Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
Health In Tech, Inc. will announce its fourth quarter and full year 2025 financial results on March 25, 2026. The announcement includes a conference call to discuss the results and business outlook. This event highlights the company's commitment to transparency and investor engagement.
Read more →Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform
Health In Tech, Inc. has announced a strategic collaboration with Ciklum to enhance its AI-driven InsurTech platform. This partnership aims to optimize administrative, sales, and analytics capabilities, leveraging Ciklum's expertise in AWS architecture and AI software development. The collaboration is expected to improve platform usability and expand market reach for Health In Tech.
Read more →